DGAP-News

Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014

DGAP-News: Novavax, Inc.
Novavax to Host Conference Call to Discuss Second Quarter 2014
Financial Results on August 6, 2014

30.07.2014 / 22:10

---------------------------------------------------------------------

ROCKVILLE, Md., 2014-07-30 22:10 CEST (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused
on the discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, announced today that it will report its financial
results for the second quarter of 2014 on Wednesday, August 6, 2014, after
market close.

In addition, management will host a conference call, to discuss the quarterly
financial results and provide an update on corporate activities. Conference
call details are as follows:

Date: August 6, 2014
Time: 4:30 PM US eastern time
Dial-in number: 1 [phone] (domestic) or 1 [phone] (international)
Via Web: www.novavax.com

Conference call Replay:

Dates: Starting at 6:31pm on August 6, 2014 until midnight October 6,
2014
Dial-in number: 1 [phone] (domestic) or 1 [phone] (international)
Passcode: 82216889
Via-Web: www.novavax.com, 'Investor Info'/'Events'

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating novel vaccines and vaccine adjuvants to address a broad range of
infectious diseases worldwide. Using innovative proprietary recombinant protein
nanoparticle vaccine technology, the company produces vaccine candidates to
efficiently and effectively respond to both known and newly emergent diseases.
Additional information about Novavax is available on the company's website,
novavax.com.


CONTACT: Barclay Phillips
SVP, Chief Financial Officer and Treasurer
Novavax, Inc.
240-268-2000
News Source: NASDAQ OMX



---------------------------------------------------------------------

30.07.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Novavax, Inc.


United States
ISIN: US6700021040


End of News DGAP News-Service
---------------------------------------------------------------------
280104 30.07.2014